MyokinE100 System: Closed Loop Electrical Muscle Stimulation to Help ICU Patients Maintain Muscle Strength
Official title: Safety and Feasibility of the MyokinE100 System in ICU Settings to Mitigate ICU Acquired Weakness
Run by Health Discovery Labs · NCT07362862 · Data updated 2026-11-12
This trial tests whether adding daily 60-minute thigh electrical muscle stimulation to standard ICU care is safe and easy for adults with sepsis or critical illness to see if it slows ICU-acquired muscle weakness.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 85 Years |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Health Discovery Labs Industry-sponsored |
| Locations | 3 sites (Rochester, Minnesota and 2 other locations) |
| Status | Recruiting |
| Started | May 5, 2026 |
| Main results expected | August 31, 2027 |
| Study ends | August 31, 2027 |
| Registry record updated | July 10, 2026 |
| Trial ID | NCT07362862 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with sepsis or severe critical illness admitted to an ICU at participating centers, eligible for EMS and able to receive thigh stimulation.
✕Probably not a fit
Patients with certain comorbidities or devices (e.g., pacemakers/ICDs), non-ambulatory baseline status, or contraindications to stimulation may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study evaluates a thigh-targeted electrical muscle stimulation device used in the ICU to see if it is safe and practical for patients at risk of muscle weakness due to critical illness or sepsis. Participants are randomized to receive standard ICU care with or without daily 60-minute sessions of electrical stimulation during their ICU stay, with muscle strength monitored over time. The trial emphasizes safety, feasibility, and potential impact on muscle weakness progression. It involves adults admitted to participating ICUs with APACHE II scores indicating severity and sepsis criteria, excluding those with conditions that could interfere with the device or care plan. Results will inform whether a closed-loop EMS approach can be integrated into critical-care rehabilitation.
Why it matters
Potential benefit: If successful, the approach could help preserve muscle strength in ICU patients and support faster recovery.
How similar studies have gone: Previous research in related electrical stimulation methods suggests potential safety and feasibility, but this exact closed-loop EMS approach in ICU patients is being explored here.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Admitted to ER or ICU within the previous 48 hours * APACHE II score ≥ 13 * Meets the criteria for sepsis or severe sepsis Exclusion Criteria: * Anticipated transfer to an ICU not participating in this study * Myopathies (e.g. congenital) * Acquired myopathies with CK levels 5-times above the upper limit of normal * Unable to transfer from bed to chair at baseline * Moribund * Comfort care * New onset deep vein thrombosis within the previous 6-months * Malignancy in lower limb * Technical obstacles - fracture, burns, amputation * Open wound or skin abrasion at the garment application site * Pregnancy * Pacemaker and implantable cardioverter-defibrillator
Where it's running
-
Mayo Clinic
Rochester, Minnesota, United States Recruiting -
Dell Seton Medical Center at The University of Texas
Austin, Texas, United States Recruiting -
Ascension Seton Medical Center Austin
Austin, Texas, United States Recruiting
Study contacts
- Principal investigator: Oussama Hassan, M.D. — Health Discovery Labs
- Study coordinator: Oussama Hassan, M.D.
- Email: O.Hassan@healthdiscoverylabs.com
- Phone: 512-203-9474
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Evaluating muscle weakness in ICU survivors through exercise testing
This study is trying to see how problems with blood flow after being in the ICU affect the strength and exercise ability of patients who survived serious illnesses like sepsis and shock.
-
Peripheral Perfusion Index trajectory to predict 28-day mortality in sepsis patients in the ICU
This study tests whether changes in a finger-based perfusion index over the first 24 hours in the ICU can predict 28-day death among adults with sepsis or septic shock.
-
Metabolic and Functional Study of γδ T Cells in Critically Ill Patients
Researchers will look at how γδ T cells behave in severely ill patients, including those with sepsis, to see how their metabolism and function change.
-
Monocyte HLA-DR monitoring to detect immune weakness in severe intra-abdominal infections at risk for fungal invasion
This will test whether measuring monocyte HLA-DR can reveal innate immune weakness in adult ICU patients with severe intra‑abdominal infections who are at risk for invasive Candida.
-
Hyperinflammation and High Ferritin in Critically Ill Patients
This study looks at critically ill patients with signs of high inflammation to see how their condition develops over time.
-
Investigating the gut microbiome's role in sepsis and brain function in critically ill patients
This study is trying to see how changes in gut bacteria from antibiotic use affect brain function and recovery in critically ill patients with severe infections or sepsis.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.